Alterity Therapeutics Limited
PRNAF
$0.0088
-$0.0013-12.87%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -10.22% | -12.80% | -115.53% | -110.22% | 19.72% |
| Total Depreciation and Amortization | -1.66% | 0.41% | 38.86% | 35.20% | 46.95% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 137.25% | 142.76% | 353.92% | 347.77% | 76.84% |
| Change in Net Operating Assets | -223.88% | -226.78% | 195.34% | 192.99% | 175.80% |
| Cash from Operations | -85.96% | -90.30% | 20.86% | 22.82% | 55.12% |
| Capital Expenditure | -- | -- | 100.00% | 100.00% | -18.75% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 100.00% | 100.00% | -18.75% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -24.45% | -24.45% | 237.89% | 237.89% | -97.12% |
| Issuance of Common Stock | -70.88% | -70.88% | 4,573.06% | 4,573.06% | 962.58% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 87.85% | 87.85% | -1,408.29% | -1,408.29% | -195.96% |
| Cash from Financing | -71.60% | -70.95% | 7,074.93% | 6,892.45% | 8,457.50% |
| Foreign Exchange rate Adjustments | -1,240.00% | -1,270.00% | -44.25% | -45.64% | -100.68% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -134.60% | -140.06% | 103.28% | 103.20% | 63.86% |
